In this new study, researchers found that the group taking probiotics had not only an overall reduction in negative emotions, ...

The phase 3 POIESIS trial is set to investigate navtemadlin as an add-on therapy to Jakafi in patients with JAK inhibitor-naive myelofibrosis.

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma ...

Daily treatment with IPL344 for up to three years was safe and slowed ALS progression in a small Phase 2a clinical trial, ...

The following is a summary of "A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors ...

Medically reviewed by Jonathan Purtell, RDN A new study has found that fasting three days each week—and eating what you want ...

For individuals experiencing depression, such interactions can be uncomfortable or emotionally taxing. People with depression ...

A remarkable new study demonstrates that embracing traditional African dietary patterns, even for just two weeks, can ...

This review examined whether switching to a different antipsychotic medicine, as opposed to continuing treatment with the same one, improved people's response rates, alleviated overall and specific ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

As AI transforms mental health care, questions about app efficacy, privacy, and ethical design highlight the need for rigorous validation and oversight.

There is growing recognition that substance use research in the United States has not always been attentive to the ...